Skip to main content
. 2013 Jun 27;15(9):1257–1263. doi: 10.1093/neuonc/not085

Fig. 1.

Fig. 1.

Linear plot of percentage change in necrosis volumes on (A) T1-weighted post-gadolinium contrast magnetic resonance imaging and (B) T2-weighted fluid-attenuated inversion recovery magnetic resonance imaging, before bevacizumab treatment, at first follow-up, at second follow-up, and after bevacizumab treatment.